An affixed group of pharmaceutical vials with frangible connectors, comprising: a plurality of pharmaceutical vials (610, 620, 630, 640, 650) arranged as an affixed group of pharmaceutical vials, each of the pharmaceutical vials including at least one external side with a substantial flat exterior wall configured to reversibly mate with a corresponding external side and a substantial flat exterior wall of an adjacent pharmaceutical vial to form a gap (615, 625, 635, 645) between each pharmaceutical vial and the adjacent pharmaceutical vial, each pharmaceutical vial including a second exterior side with a second surface configured to reversibly mate with a surface of a support, the support comprising a substantially planar structure of a similar height and width as the affixed group of pharmaceutical vials, and including at least one surface configured to reversibly mate with the second surface of each of the plurality of pharmaceutical vials; a first set of frangible connectors (200, 210, 220, 230), wherein at least one frangible connector of the first set of frangible connectors is affixed to the substantial flat exterior wall of at least two of the plurality of pharmaceutical vials within the group of pharmaceutical vials, and at least one frangible connector of the first set of frangible connectors is affixed to each of the plurality of pharmaceutical vials and positioned within the gap between each pharmaceutical vial and the adjacent pharmaceutical vial; and a second set of frangible connectors (655, 660), wherein the second surface of each pharmaceutical vial is affixed to at least one frangible connector of the second set of frangible connectors, and each frangible connector of the second set of frangible connectors is affixed to the support in order to affix the plurality of pharmaceutical vials arranged in the affixed group to the support, thereby minimizing a total volume of the group of pharmaceutical vials. a plurality of pharmaceutical vials (610, 620, 630, 640, 650) arranged as an affixed group of pharmaceutical vials, each of the pharmaceutical vials including at least one external side with a substantial flat exterior wall configured to reversibly mate with a corresponding external side and a substantial flat exterior wall of an adjacent pharmaceutical vial to form a gap (615, 625, 635, 645) between each pharmaceutical vial and the adjacent pharmaceutical vial, each pharmaceutical vial including a second exterior side with a second surface configured to reversibly mate with a surface of a support, the support comprising a substantially planar structure of a similar height and width as the affixed group of pharmaceutical vials, and including at least one surface configured to reversibly mate with the second surface of each of the plurality of pharmaceutical vials; each of the pharmaceutical vials including at least one external side with a substantial flat exterior wall configured to reversibly mate with a corresponding external side and a substantial flat exterior wall of an adjacent pharmaceutical vial to form a gap (615, 625, 635, 645) between each pharmaceutical vial and the adjacent pharmaceutical vial, each pharmaceutical vial including a second exterior side with a second surface configured to reversibly mate with a surface of a support, the support comprising a substantially planar structure of a similar height and width as the affixed group of pharmaceutical vials, and including at least one surface configured to reversibly mate with the second surface of each of the plurality of pharmaceutical vials; a first set of frangible connectors (200, 210, 220, 230), wherein at least one frangible connector of the first set of frangible connectors is affixed to the substantial flat exterior wall of at least two of the plurality of pharmaceutical vials within the group of pharmaceutical vials, and at least one frangible connector of the first set of frangible connectors is affixed to each of the plurality of pharmaceutical vials and positioned within the gap between each pharmaceutical vial and the adjacent pharmaceutical vial; and a second set of frangible connectors (655, 660), wherein the second surface of each pharmaceutical vial is affixed to at least one frangible connector of the second set of frangible connectors, and each frangible connector of the second set of frangible connectors is affixed to the support in order to affix the plurality of pharmaceutical vials arranged in the affixed group to the support, thereby minimizing a total volume of the group of pharmaceutical vials.